Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome - sprookjes - yvandenbroek - TriplyDB

Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome

Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome

http://www.wikidata.org/entity/Q27471683

about

Effect of oligonucleotide primers in determining viral variability within hosts Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy Viral quasispecies evolution Wide range of quasispecies diversity during primary hepatitis C virus infection An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein Characterization of hepatitis C virus quasispecies by matrix-assisted laser desorption ionization-time of flight (mass spectrometry) mutation detection.Hepatitis C Virus NS3 ATPases/Helicases from Different Genotypes Exhibit Variations in Enzymatic Properties Viral Determinants of Resistance to Treatment in Patients with Hepatitis C Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4 Monitoring of Hepatitis C Virus Quasispecies in Chronic Infection by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Mutation Detection The West Nile virus mutant spectrum is host-dependant and a determinant of mortality in mice Influence of increased CD4 cell counts on the genetic variability of hepatitis C virus in patients co-infected with human immunodeficiency virus I Genetic variation in West Nile virus from naturally infected mosquitoes and birds suggests quasispecies structure and strong purifying selection Correlation between pre-treatment quasispecies complexity and treatment outcome in chronic HCV genotype 3a Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C Investigation of Putative Multisubtype Hepatitis C Virus Infections In Vivo by Heteroduplex Mobility Analysis of Core/Envelope Subgenomes Genetic Variability of Hepatitis C Virus before and after Combined Therapy of Interferon plus Ribavirin Influence of quasispecies on virological responses and disease severity in patients with chronic hepatitis C Full-Length Characterization of Hepatitis C Virus Subtype 3a Reveals Novel Hypervariable Regions under Positive Selection during Acute Infection The quasispecies nature and biological implications of the hepatitis C virus Hepatitis C Virus (HCV) Quasispecies Complexity and Selection in HCV/HIV‐Coinfected Subjects Treated with Interferon‐Based Regimens Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy response Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencing Genetic Variability of Hepatitis C Virus (HCV) 5' Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin Evasion of intracellular host defence by hepatitis C virus Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents Increased replicative fitness of a dengue virus 2 clade in native mosquitoes: potential contribution to a clade replacement event in Nicaragua.Evolution of the uniquely adaptable lentiviral envelope in a natural reservoir host.Development of a heterologous, multigenotype vaccine against hepatitis C virus infection.Topology of evolving, mutagenized viral populations: quasispecies expansion, compression, and operation of negative selection.Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected patients by discriminant analysis using viral and host factors Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection.Homogeneity of Powassan virus populations in naturally infected Ixodes scapularis.Identification of HCV Resistant Variants against Direct Acting Antivirals in Plasma and Liver of Treatment Naïve Patients Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes.Hepatitis C virus transmission bottlenecks analyzed by deep sequencing.Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection.Hepatitis C virus quasispecies in chronically infected children subjected to interferon-ribavirin therapy Deep sequencing of hepatitis C virus hypervariable region 1 reveals no correlation between genetic heterogeneity and antiviral treatment outcome

P2860

Q24798391-4A1EF0C2-905D-4068-B841-594AAE7430F1 Q26853500-0039F6C9-44B0-4B3F-A247-863DCE5A5E06 Q27013917-DE6EE96D-9556-4168-977D-4C39E9E5115D Q27469430-3B09B159-D078-4AA9-86D3-1AF50955ABE8 Q27469837-6B387AF1-5DE2-462C-97F7-89280DC042FB Q27470798-B54C1E1E-1145-410A-A951-399A59267E5C Q27472751-3A441BF8-CF91-4139-AD5A-E6BBEA4ACF4D Q27473372-BC790F9B-2D77-4C12-8C9C-6178ED113AC0 Q27478062-700E3BE3-0C3F-4657-83C3-D2809C5011A1 Q27478102-2FF2F28F-EEE7-473B-AF0C-4911ECD792A0 Q27478186-6DEB78DB-3604-40CE-91C6-BDB9B42F6A1C Q27480939-B17E905B-4978-4932-B6F4-B91FA9C10B91 Q27485710-72841744-BF8A-45B7-8D71-A60C9A60B398 Q27486388-3AE6C40D-FD63-4FB6-ABF5-CF191182A611 Q27486521-EE934228-AD79-47C8-988E-46483AEE52C0 Q27486537-7BC929AA-6E4A-4199-A095-21EDE480F823 Q27486577-345F4573-24B6-46B8-B63F-C10D49E7999C Q27486648-BA0999D8-3EF7-42BC-9EA3-9CF92FF74157 Q27488410-7E4F08A2-B0A7-4082-AF04-81FBF581620C Q27490315-71D7726E-F7A0-4AE8-8321-B97DBBFBDEA8 Q27490497-59718576-E23A-4474-ABC9-12A6E778D153 Q27490972-BEDE13E1-F221-4A43-B63F-98B779CE49E6 Q27491275-8FD781CC-AB43-4CE4-9F25-A3CFE09AA41F Q28477175-39E62B1C-04E5-48DC-9428-C8D533CDF629 Q28546960-AE8DA13C-1F7A-40CA-AF08-2B2D55C2DD09 Q29618976-3E689E6E-7DEE-431B-AF62-7C2F68521478 Q30365599-A530903F-55A0-46BC-B879-3D5CB9263626 Q30847507-A20F9E69-6DCF-4970-8976-B35A0E5BDD02 Q31034710-0EC0758C-EF65-41CC-BD72-1F7AB0498AA3 Q33282900-E5F44C44-8F8D-4AD3-A8DA-0A1410D0667F Q33352819-4F29745C-C79E-4DAE-A825-A24EE04DA2B9 Q33770280-B371DBFE-99E9-4D49-B8BE-AF4349DF4C43 Q33834509-98C31373-D5D9-4B75-8B1C-52B936C61ED2 Q33872270-E60D46A1-9186-42D5-B664-6E17124C774A Q33875539-EA9BA242-13B2-456E-B77F-40BD0164CDF9 Q33877342-35FF5818-FE57-4160-B707-D78761AEF5A3 Q33877425-DDDEA0CB-DAA1-48D7-BAB5-21840AD83E94 Q33908879-9A4D9D98-7D44-49CC-A60A-CC404CFC7DBD Q34316603-E898142A-13F2-42C2-B3F9-8D98D2D23878 Q34485144-753FEAA3-63C1-43F2-B337-9231F19E166A

P2860

Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome

http://www.wikidata.org/entity/Q27471683

description

2002 nî lūn-bûn

@nan

2002 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մարտին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Early changes in hepatitis C v ...... redict the therapeutic outcome

@ast

Early changes in hepatitis C v ...... redict the therapeutic outcome

@en

Early changes in hepatitis C v ...... redict the therapeutic outcome

@nl

type

label

Early changes in hepatitis C v ...... redict the therapeutic outcome

@ast

Early changes in hepatitis C v ...... redict the therapeutic outcome

@en

Early changes in hepatitis C v ...... redict the therapeutic outcome

@nl

prefLabel

Early changes in hepatitis C v ...... redict the therapeutic outcome

@ast

Early changes in hepatitis C v ...... redict the therapeutic outcome

@en

Early changes in hepatitis C v ...... redict the therapeutic outcome

@nl

P1433

Q27471683-9F9CE34E-E636-4A48-8513-8BB282515823

P1476

Q27471683-FE98A63B-3A41-4E72-A22F-E979B81B0502

P2093

Q27471683-2046459B-1EB0-4B52-B27D-E5F52846A908

Q27471683-384BD87F-5747-4497-9DFF-41E4C80FE14C

Q27471683-509C9B5D-C160-45CC-A0EA-60B1BE6CA10B

Q27471683-6442D254-CD80-40F4-B7E5-22C8323496DC

Q27471683-77EF8FE3-5EE5-438D-9382-B5857C5EE25C

Q27471683-887AF513-ED05-4DCB-BF47-9479D47797E0

Q27471683-9B9F3A39-9C92-4AE8-AE0E-0085F9485BD0

Q27471683-A7670095-8BCD-4CE3-8F49-0152C20D468E

Q27471683-B6584617-6B1D-47FF-805C-BBBB58409FCA

Q27471683-D1255B3D-0F6A-40C6-8667-F87CA791C613

P2860

Q27471683-071CD609-A8C4-4858-8534-7931FBDF92D0

Q27471683-0AF3F13A-4C9A-4F1D-9B9E-A896C9EA235A

Q27471683-17321DFE-1D1B-47B6-BFA5-BEA10D2A9973

Q27471683-1F8449CD-3B47-43CF-8C34-84D799A2D3A5

Q27471683-200572DC-676A-4592-8C7A-DED7405E2E1F

Q27471683-234C8E85-55F0-41BD-81A6-30C051C1099D

Q27471683-2A6339CE-354F-45AD-8578-13CBD61C697E

Q27471683-2BBB7D21-F02B-45B2-81F9-8EA32AE3F52C

Q27471683-378ACFB2-2761-4E4C-B9F3-5587478DBBA6

Q27471683-3BD5BB4B-E0E2-4490-9978-EC2F5A5DCA8D

P304

Q27471683-F7713FE8-AF51-488A-AEAE-154F4EAA57F9

P31

Q27471683-81AB2F38-CECF-4C94-94EC-CA44AEEBB7FF

P356

Q27471683-2803A880-6C2D-4983-87CD-F0B67904AA6E

P407

Q27471683-683C32B3-9B8B-498A-8209-952E91C44B6F

P433

Q27471683-95382C5A-8EBA-42E4-A56B-C3A2B7B8696E

P478

Q27471683-39901A57-B9D3-426B-8021-A108B1DCDC23

P577

Q27471683-D345C0A4-AEA5-49DD-BB0E-AE76C21FE8FB

P5875

Q27471683-3CA469F5-3B97-4238-BFBC-1CE4A7BF173A

P698

Q27471683-41B03D43-B07A-4542-B3A1-43284C56B523

P932

Q27471683-7E46E380-6C73-460A-8A42-953F8DC07643

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Early changes in hepatitis C v ...... redict the therapeutic outcome

@en

P2093

Alessandra Coiana

http://www.w3.org/2001/XMLSchema#string

Angelo Balestrieri

http://www.w3.org/2001/XMLSchema#string

Daniela Degioannis

http://www.w3.org/2001/XMLSchema#string

Francesco Usai

http://www.w3.org/2001/XMLSchema#string

Giacomo Diaz

http://www.w3.org/2001/XMLSchema#string

Giancarlo Serra

http://www.w3.org/2001/XMLSchema#string

Giovanna Peddis

http://www.w3.org/2001/XMLSchema#string

Harvey J Alter

http://www.w3.org/2001/XMLSchema#string

Luchino Chessa

http://www.w3.org/2001/XMLSchema#string

Patrizia Farci

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy

Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy.

Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections

P304

3081-3086

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.052712599

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11481670

http://www.w3.org/2001/XMLSchema#string

P698

11880647

http://www.w3.org/2001/XMLSchema#string

P932

122476

http://www.w3.org/2001/XMLSchema#string